BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38639911)

  • 21. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
    Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
    Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
    Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
    Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis.
    Datta D; Selvakumar B; Goel AD; Chhibber S; Varshney VK; Kumar R
    Ann Nucl Med; 2024 May; ():. PubMed ID: 38750330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
    Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
    Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma.
    Hur BY; Lee JM; Lee JE; Park JY; Kim SJ; Joo I; Shin CI; Baek JH; Kim JH; Han JK; Choi BI
    J Magn Reson Imaging; 2012 Jul; 36(1):188-97. PubMed ID: 22371378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
    Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
    Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum IgG4 and IgG for the diagnosis of autoimmune pancreatitis: A systematic review with meta-analysis.
    Lian MJ; Liu S; Wu GY; Liu SY
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):99-109. PubMed ID: 26160477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantified ADC histogram analysis: a new method for differentiating mass-forming focal pancreatitis from pancreatic cancer.
    Ma X; Zhao X; Ouyang H; Sun F; Zhang H; Zhou C
    Acta Radiol; 2014 Sep; 55(7):785-92. PubMed ID: 24167322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical differences between mass-forming autoimmune pancreatitis and pancreatic cancer.
    Naitoh I; Nakazawa T; Hayashi K; Okumura F; Miyabe K; Shimizu S; Kondo H; Yoshida M; Yamashita H; Ohara H; Joh T
    Scand J Gastroenterol; 2012 May; 47(5):607-13. PubMed ID: 22416894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinguishing pancreatic cancer and autoimmune pancreatitis with in vivo tomoelastography.
    Zhu L; Guo J; Jin Z; Xue H; Dai M; Zhang W; Sun Z; Xu J; Marticorena Garcia SR; Asbach P; Hamm B; Sack I
    Eur Radiol; 2021 May; 31(5):3366-3374. PubMed ID: 33125553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions.
    Kang KM; Lee JM; Yoon JH; Kiefer B; Han JK; Choi BI
    Radiology; 2014 Feb; 270(2):444-53. PubMed ID: 24126370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IVIM DW-MRI of autoimmune pancreatitis: therapy monitoring and differentiation from pancreatic cancer.
    Klauß M; Maier-Hein K; Tjaden C; Hackert T; Grenacher L; Stieltjes B
    Eur Radiol; 2016 Jul; 26(7):2099-106. PubMed ID: 26449558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer.
    Sugiyama Y; Fujinaga Y; Kadoya M; Ueda K; Kurozumi M; Hamano H; Kawa S
    Jpn J Radiol; 2012 May; 30(4):296-309. PubMed ID: 22237599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Diagnostic Performance of Maximum Uptake Value and Apparent Diffusion Coefficient in Differentiating Benign and Malignant Ovarian or Adnexal Masses: A Meta-Analysis.
    Hu X; Liang Z; Zhang C; Wang G; Cai J; Wang P
    Front Oncol; 2022; 12():840433. PubMed ID: 35223521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of diffusion-weighted imaging in distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis: a meta-analysis.
    Niu X; Das SK; Bhetuwal A; Xiao Y; Sun F; Zeng L; Wang W; Yang H; Yang H
    Chin Med J (Engl); 2014; 127(19):3477-82. PubMed ID: 25269917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging.
    Zhang TT; Wang L; Liu HH; Zhang CY; Li XM; Lu JP; Wang DB
    Oncotarget; 2017 Jan; 8(1):1744-1759. PubMed ID: 27661003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifocal autoimmune pancreatitis: A retrospective study in a single tertiary center of 26 patients with a 20-year literature review.
    Huang XM; Shi ZS; Ma CL
    World J Gastroenterol; 2021 Jul; 27(27):4429-4440. PubMed ID: 34366614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted MR imaging of pancreatic cancer and inflammation: Prognostic significance of pancreatic inflammation in pancreatic cancer patients.
    Hayano K; Miura F; Wada K; Suzuki K; Takeshita K; Amano H; Toyota N; Sano K; Asano T
    Pancreatology; 2016; 16(1):121-6. PubMed ID: 26596539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of DWI with quantitative ADC values in ovarian tumors: a meta-analysis of diagnostic test performance.
    Pi S; Cao R; Qiang JW; Guo YH
    Acta Radiol; 2018 Nov; 59(11):1386-1394. PubMed ID: 29463093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.